Blood-brain barrier (BBB) permeability in the demented elderly was investigated by use of the ratio of cerebrospinal fluid (CSF) albumin (Alb) to serum Alb (Q-Alb). Subjects with Alzheimer type dementia (AD), vascular dementia (VD), and controls without dementia (C) were investigated. Patients with AD were divided into mild AD (mAD) and severe AD (SAD) by the use ofHasegawa's dementia scale. The Q-Alb and the ratio of CSF arantichymotrypsin (ACT) to serum ACT (Q-ACT) were evaluated. Correlations between Q-Alb and Q-ACT were compared among the groups (mAD, SAD, VD, C). Correlations between Q-Alb and major monoaminergic neurochemicals were also analyzed. It was suggested that BBB permeability was preserved in C group, while it was impaired in the patients with VD. In AD group it appeared to be rather well preserved in mAD, while it seemed to be disturbed in a graded manner according to the progression of dementia. (Internal Medicine 37: 509-513, 1998) 
Introduction
Recent progress of research on senile dementia of the Alzheimer type (AD) revealed that there might exist some diagnostic biological markers, such as arantichymotrypsin (ACT) in cerebrospinal fluid (CSF) ( 1). In the previous reports it was shown that the concentrations of ACT in CSF of probable AD were significantly elevated compared with those of controls orpatients with othertypes of dementia (1 , 2). It was also shown that the CSF ACT level correlated significantly with the scale of dementia, i.e. Hasegawa' s dementia scale (HDS), implying that ACT might reflect the severity of the intellectual dysfunction. The correlations between ACT levels in CSF or HDS score and concentrations of multiple neurochemicals (catecholaminergic and indoleaminergic) in CSF, such as homovanillic acid (HVA) or the ratio of kynurenine (KYN) to tryptophan (TRP) (KYN/TRP), were also investigated to find several possible diagnostic biological markers reflecting the degree of mental function, as reported previously (2). In the daily clinics of demented patients, many elderly persons with AD show various atypical symptoms suggesting other etiological diseases of dementia, such as cerebrovascular diseases or inflammatory diseases to which abnormalities of the permeability of the blood-brain barrier (BBB) might be related (3-5).
Several reports have concerned the abnormalities of BBB in cerebral ischemia and vascular dementia (6-10).
However, only a few reports have focused on the abnormal permeabilities of BBB in AD. Historically BBB dysfunction in AD was suggested by Wisniewski and Kozlowski (1 1), and Alafuzoffet al ( 1 2), whereas no evidence for abnormal penetration ofbloodborne proteins was found in another study by Jonker et al (13 (20) . In the present report the results of the CSF-serum albumin ratio (Q-Alb) in demented elderly were investigated more in depth. Q-Alb is thought to be a marker of the permeability of the BBB in neuropsychological diseases (21) . Kirch et al (22) investigated Q-Alb in schizophrenia and Niklasson and Agren (23) reported on Q-Alb in depression, but their results were not specific to these psychotic diseases. In this report correlations between Q-Alb and CSF-serum ACT ratio (Q-ACT), and the correlations between Q-Alb and concentrations of major monoamine metabolites, 3 -methoxy-4-hydroxyphenyl-glycol (MHPG), homovanillic acid (HVA), and 5-hydroxy-indole-3-acetic acid (5-HIAA) in CSF were investigated in attempt to find the abnormal permeabilities of the BBB in dementing diseases. It was highly suggested that BBB permeability is compromized in patients with vascular dementia, while in patients with AD it appeared to be impaired in a graded fashion as the disease advanced. The obtained results may contribute to a better understanding of the biochemical pathogenesis of both vascular dementia and senile dementia of the Alzheimer type.
Subjects and Methods
A total of 28 institutionalized patients in the Department of Geriatrics, University of Tokyo Hospital was selected for the present investigation; in which 14 patients (AD group) (4 males, 10 females) with a mean ± SEM age of77.6± 0.3 years (range 62-89) fulfilled theTNflNCDS-ADRDA criteria (24) of probable AD, 7 patients (VD group) (4 males, 3 females) with a mean ± SEM age of74.4 ± 3.1 years (range 56-84) belonged to vascular dementia according to the NINDS-AIREN criteria (25) and the other 7 patients (C group) (4 males, 3 females) with a mean ± SEM age of 78.6 ± 2.4 years (range 67-87) were selected for control subjects without dementia, who had no organic disease affecting the higher cortical functions. AD group was divided into mild AD group (n=7) and severe AD group (n=7) by the score of HDS, where the score of 10 was taken as a boundary value dividing the two groups. Lumbar puncture was performed for each patient with informed consent before breakfast and part of the obtained CSF sample was examined for the routine laboratory test including Alb and ACT concentrations and the rest was kept frozen (-80°C) until analysis of the monoaminergic neurochemicals. At the same time a blood sample was obtained for the analysis of serum Alb and ACT concentrations. The concentrations of albumin in CSF and serum were determined by Latex aggregation method and Brom-CresolGreen method, respectively. The concentrations of ACT in CSF and serum were also determined by means of the enzymelinked immunosorbent assay (ELISA) (26). The concentrations of neurochemicals (MHPG, HVA, 5-HIAA) in CSF were determined by the use of a multi-electrode array system (a neurochemical analyzing system, ESA), as described in previous articles (2, 27). The ratio ofAlb concentrations in CSF and serum, i.e. Q-Alb, was evaluated as follows:
Q-Alb = Alb(CSF)/Alb(serum). Q-Alb Q-Alb in AD (10.2 ± 0.8xl0"3) and VD (10.3 ± O.8xlO~3) groups were higher than that in C group (7.37 ± 1.21xlO~3) (p<0.001). No significant differences were observed between AD and VD groups. Serum ACT in AD (629 ± 77 jug/ml) was higher than those of VD (572 ± 36 |Ug/ml) and C (560± 78 (ig/ml) groups. It was significantly higher than that in VD group (p<0.05)
but not than C group. C SF ACT CSF ACT inAD (6.33 ± 0.73 |Ug/ml) group was significantly higherthan those in VD (5.45 ± 0.75 jag/ml) and C (3.49 ± 0.45 |Lig/ml) groups (p<0.05 and p<0.001 , respectively). showed a tendency to correlate with HVA (r2=0.4984, p<0. 1) but not with MHPG nor 5-HIAA. These results of the correlations described above were summarized in Table 2 .
Discussion
For a standard review of BBB, the report by Goldstein and Betz includes the history of investigation about BBB (28). In this study the statistical analysis between Q-Alb, which is a marker of the permeability of BBB, and Q-ACT revealed characteristics of the BBB permeability in demented patients. Q-Alb correlated significantly with Q-ACT with a high correlation coefficient (r=0.9060) in C group. In VD group the correlation between Q-Alb and Q-ACT was not significant. In AD group the correlation between Q-Alb and Q-ACT was significant. In mild AD group this correlation coefficient (r=0.9252) was especially high, and similar to C group. In severe AD group, however, this correlation coefficient (r=0.3497) became statistically not significant, similar to VD group (r=0.1943). These similarities among the groups were visualized in Fig. 1 . From the obtained results it is suggested that the permeability of BBB in C group is rather well preserved, while it is impaired in VD group and the correlation between Q-Alb and Q-ACT might be indicative ofcompromized BBB permeability in AD group as a function of the progression of the disease.
The investigation of the correlation between Q-Alb and the concentrations of 3 monoamine metabolites (MHPG, HVA, and 5-HIAA) further clarified the characteristics of the BBB permeability in demented patients, as described above. In C group, Q-Alb showed a tendency to correlate with MHPG, a noradrenergic metabolite, but not with HVA nor 5-HIAA, dopaminergic and serotonergic metabolites, respectively. This finding may imply that BBB permeability might be regulated by noradrenergic fibers in the normal state. In VD group Q-Alb correlated with MHPG, HVA and 5-HIAA with nearly the same correlation coefficients although not significant. This finding seems to indicate that the BBB permeability in VD might be regulated not only by noradrenergic but also by dopaminergic and serotonergic fibers. It was reported that various types of cerebrovascular insults are associated with the elevation of brain serotonin levels and impaired B BB (29), with which the present result might agree. In AD group Q-Alb showed a tendency to correlate with HVA. In mild AD, Q-Alb showed a tendency to correlate with MHPG similar to the situation in C group. In severe AD group Q-Alb showed a tendency to correlate with HVA similar to the situation in the total AD group. The BBB permeability might be regulated by noradrenergic fibers in the mild stage of AD similar to C group, but it might be changed gradually to be regulated by dopaminergic fibers with the progression of the degenerative disease.
The BBB permeability is known to be regulated by central noradrenergic fibers which originate in the locus ceruleus in normal cerebral vessels (30, 3 1) In conclusion it was shown that BBB permeability in dementing disorders was compromized according to the etiology ofthe disease, vascular dementia or Alzheimer type dementia. Further study is necessary to clarify more fully the BBB disorder not only biochemically but also pathologically. 
